LWCFA
MIRM icon

Loring Wolcott & Coolidge Fiduciary Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.5K Hold
278
– – ﹤0.01% 467
2026
Q1 		$26.5K Hold
278
– – ﹤0.01% 468
2025
Q4 		$27.6K Buy
+278
New +$20K ﹤0.01% 458

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's MIRM Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 278 shares worth $32.5K. The position accounts for ﹤0.01% of the portfolio, ranked #467.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 278 shares of Mirum Pharmaceuticals worth $32.5K as of Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #467 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.